$TXN

UBS Research Analysis: Analog Chip Cycle Continues Upward, Inventory Falls to Low Levels

UBS Group reports that analog chip inventory has fallen 7-10% quarter-over-quarter, while prices rose 9-12%, driven by strong demand and supply constraints. Texas Instruments (TXN) is their top pick, with Q3 revenue expected to grow 10.7% quarter-over-quarter, exceeding seasonal norms. Analog Devices (ADI), Microchip Technology (MCHP), and onsemi (ON) also show strong earnings forecasts.

Original reporting
Published Oct 19, 2026, 4:29 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 5:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS Research Analysis: Analog Chip Cycle Continues Upward, Inventory Falls to Low Levels — source image
Decision brief

The 30-second read

$TXNBullishMed
01

Why it matters

The report provides fresh quantitative guidance and a top‑pick recommendation, offering traders new data to adjust positions.

02

Market read

Analyst upgrades for several analog chip makers could drive sector‑wide buying, especially in Texas Instruments.

03

What to watch

Potential macro slowdown or competition from emerging analog players could temper growth.

Relevance 6/10Novelty 6/10Timing: immediate

Background

UBS released a US Semiconductor research note on Oct 16, updating its analog chip cycle outlook and earnings forecasts for key players.

Company-level read

Ticker impact

$TXNBullishHigh confidence
Context

UBS upgrades Texas Instruments earnings outlook, forecasting Q3 revenue growth of 10.7% QoQ and naming it the top pick in the analog chip cycle.

Expected impact

likely upward pressure as investors price in stronger growth and top‑pick status.

Evidence & confidence

Analyst forecast exceeds seasonal benchmarks and highlights inventory advantage, which typically drives buying.

$ADIBullishMedium confidence
Context

UBS projects Analog Devices Q3 revenue to grow 8.5% QoQ, above the seasonal norm, and cites it as a favorable earnings story.

Expected impact

potential modest rally as the forecast beats expectations.

Evidence & confidence

Growth estimate is higher than seasonal, but less pronounced than TXN.

$MCHPBullishMedium confidence
Context

UBS expects Microchip Technology Q3 revenue growth of 8.5% QoQ, surpassing the seasonal benchmark, and notes its nine‑point plan execution.

Expected impact

possible slight upside as inventory days improve.

Evidence & confidence

Forecast is solid; inventory reduction may be viewed favorably.

$ONBullishMedium confidence
Context

UBS forecasts onsemi Q3 revenue growth of 5.4% QoQ, ahead of the seasonal rate, and highlights strengthening True Analog pricing.

Expected impact

likely modest upward pressure.

Evidence & confidence

Growth above seasonal and pricing tailwinds support a small rally.

$ALGMBearishMedium confidence
Context

UBS projects Allegro Q3 revenue growth of 6.0% QoQ, lagging the seasonal benchmark of 7.1%, indicating weaker performance.

Expected impact

potential downside pressure as growth underperforms expectations.

Evidence & confidence

Growth below seasonal norm suggests weaker demand for Allegro's products.

Market effects

Analyst optimism may lift the broader analog semiconductor sector, supporting related stocks.

U.S. semiconductor exposure gains favor, with limited direct effect on other regions.

Signals continued strength in analog components, relevant for global supply chains.

Counterpoint

If inventory levels remain low longer than expected, demand could soften, hurting the upside thesis.

Key entities

  • UBS Group

    Issuer of the analyst report providing the forecasts.

  • Texas Instruments

    Top pick with strongest growth outlook.

Related articles

$TXNMedAI 8/10

Texas Instruments Stocks Slip Despite Broad Chip Recovery

Texas Instruments reported Q3 revenue of $6.06B and EPS of $2.62, with shares down 1.20% on Oct 22. Sales grew 28% YoY and 11% QoQ, driven by industrial, automotive, and data-center sectors. Management forecasts Q4 revenue between $5.80B-$6.30B and EPS between $2.45-$2.79. Shares trade 17.07% above GF Value estimate.

$TXNHigh

Texas Instruments stock rating upgraded at Freedom Broker on margins

Freedom Broker upgraded Texas Instruments (TXN) to Buy, raising its price target to $330. The firm cited strong Q3 results, with revenue and margins beating expectations. TXN's revenue grew 17% YoY, and it raised its dividend for 23 consecutive years. Analysts highlight demand in industrial, data center, and automotive sectors, with mixed price target adjustments.

$TXNHighAI 8/10

Texas Instruments earnings analysis: questions answered and next catalysts

Texas Instruments (TXN) reported Q3 FY2026 earnings with EPS of $2.62 (beating estimates by 8.26%) and revenue of $6.06B. The stock is trading at $281.10, 16% below its 52-week high. Revenue grew 28% YoY, with data center revenue up 95%. Gross margin reached 64%. Q4 guidance is $5.8B–$6.3B revenue and $2.45–$2.79 EPS. Analysts have mixed views on valuation and future growth.

$TSLAMed

Tesla Will Make Millions of Optimus Robots. Texas Instruments Can Get Paid on Every One

Tesla (TSLA) began production of Optimus robots in Fremont, aiming for millions, but disclosed no unit volumes. Texas Instruments (TXN) reported chip content of $500-$1,000 per humanoid robot, without naming Tesla as a customer. TI closed at $284.65, up 2.47%, and Tesla at $386.47, up 3.41%. TI's robotics revenue could reach $500M-$1B annually, but faces competition and Tesla's in-house silicon plans.